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Abstract
Background  and  objectives:  Success  rate  of  catheter  applications  is  low  in  supraclavicular
block.  Thus,  bupivacaine  and  levobupivacaine  become  important  with  their  long  effect  time  in
single  injection  practices.  In  this  study,  we  aimed  to  compare  the  effectiveness,  side  effects
and  complications  of  bupivacaine  and  levobupivacaine  in  supraclavicular  block.
Methods: Sixty  patients  aged  between  20  and  65,  with  body  weight  between  50  and  100  kg,  in
the  ASA  I-II-III  group  who  were  scheduled  for  hand,  forearm  and  arm  surgery  using  supraclavicu-
lar  block  were  randomized  into  two  groups  of  30.  The  patients  received  30  ml  0.5%  bupivacaine
(Group  B)  or  30  ml  0.5%  levobupivacaine  (Group  L).  Motor  and  sensory  blocks  were  evaluated.
Motor  and  sensory  block  onset  times,  total  block  durations,  postoperative  pain,  amount  of
postoperative  analgesic  used  and  patient  satisfaction  were  recorded.
Results: Demographic  data,  distribution  of  surgical  area  and  hemodynamic  data  were  similar
between the  two  groups.  Surgery,  motor  and  sensory  block  durations  of  Group  B  and  L  patients
did  not  vary  statistically  signiﬁcantly.  However,  motor  and  sensory  block  onset  times  in  Group
B  were  signiﬁcantly  shorter  than  Group  L  (p  <  0.05).  The  mean  time  for  ﬁrst  postoperative
analgesic demand  were  16.6  ±  8.0  h  in  Group  B  and  14.4  ±  7.3  h  in  Group  L  (p  >  0.05).
Conclusion:  30  ml  0.5%  bupivacaine  and  levobupivacaine  provide  similar  block  characteristics
for supraclavicular  block.  Bupivacaine  leads  to  faster  motor  and  sensory  block  onset  compared
to  levobupivacaine  however  similar  duration  of  postoperative  analgesia.
© 2013  Sociedade  Brasileira  de  Anestesiologia.  Published  by  Elsevier  Editora  Ltda.  
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Este é um artigo Open Access sob a licença de CC BY-NC-NDIntroductionCurrently  bupivacaine  is  one  of  the  most  commonly  used
local anesthetic  for  central  and  peripheral  nerve  blocks.
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http://dx.doi.org/10.1016/j.bjane.2013.03.015owever,  it  has  a  potential  to  cause  serious  cardiovascular
ide effects  and  the  new  local  anesthetic  levobupivacaine
s reported  to  be  safer  in  this  respect.1,2 The  experience
ith levobupivacaine  is  limited  in  peripheral  blocks  when
ompared to  bupivacaine.
Supraclavicular  block  enables  a  complete  anesthesia  to
he arm,  elbow  and  hand.  Postoperative  analgesia  requires
 catheter  insertion  perineurally,  however  success  rate  of
lsevier Editora Ltda. Este é um artigo Open Access sob a licença de CC BY-NC-ND
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atheter  applications  in  supraclavicular  block  is  lower  than
ther brachial  plexus  nerve  block  sites.  An  another  way  of
roviding postoperative  analgesia  is  to  use  local  anesthet-
cs with  long  duration  of  action.  Long  term  postoperative
nalgesia with  a  single  application  is  possible  with  the  use
f bupivacaine,  levobupivacaine  or  ropivacaine.  Thus  we
imed to  compare  bupivacaine  with  its  S(+)  enantiomer,  lev-
bupivacaine  in  terms  of  their  effectiveness,  side  effects
nd complications  in  supraclavicular  block.
ethods
rior  to  the  study,  approval  of  the  hospital  ethics  committee
Dr Lütﬁ  Kırdar  Research  and  Education  Ethics  Committee,
ate: 29-03-2007,  Number:  3)  has  been  obtained.
Sixty  patients  aged  between  20  and  65  years,  weighing
etween 50  and  100  kg  and  at  ASA  I-II-III  physical  condi-
ion who  were  scheduled  for  elective  hand,  forearm  or  arm
urgery were  included  in  this  study.  A  written  informed  con-
ent of  participating  patients  were  obtained.
Exclusion  criteria  included  being  classiﬁed  as  ASA  risk
lassiﬁcation of  IV  or  above,  analgesic  drug  intake  in  the
ast 24  h,  coagulation  anormalities,  having  infection  or
revious surgery  in  the  operative  site,  anatomic  deforma-
ions on  block  site,  presence  of  neurological  deﬁciencies
n the  operative  extremity,  uncooperable  patients,  suf-
ering a  peripheral  nerve  disorder,  undergoing  psychiatric
reatment, alcohol  and/or  drug  abuse,  known  allergy  to
tudy medications,  and  having  diaphragm  paralysis  and/or
neumothorax on  the  contralateral  side  to  be  oper-
ted.
Patients who  participated  in  the  study  were  randomly
ivided into  two  groups  of  30  individuals  in  each  with
 computer  generated  randomization  list  (Group  B:  30  ml
.5%, 5  mg/ml  bupivacaine;  Group  L:  30  ml  0.5%,  5  mg/ml
evobupivacaine). Patients  were  taken  to  the  regional  anes-
hesia section  within  the  operating  theater  1  h  prior  to
urgery. They  were  laid  in  supine  position  on  the  block  table.
aseline hemodynamic  parameters  [systolic  arterial  pres-
ure (SAP),  diastolic  arterial  pressure  (DAP),  mean  arterial
ressure (MAP),  heart  rate  (HR),  peripheral  oxygen  satu-
ations (SpO2)]  and  electrocardiograms  were  monitorized.
ll values  were  measured  prior  to  the  block  and  recorded
s control  values.  Venous  access  was  obtained  by  using
 20  G  branula  and  crystalloid  infusion  was  initiated.  As
 premedication,  0.03  mg/kg  iv  midazolam  was  adminis-
ered.
The point  where  block  would  be  administered  was  iden-
iﬁed by  using  the  classical  technique.3 Stimuplex  HNS  12®
B.  Braun,  Melsungen,  Germany)  was  used  as  nerve  stim-
lator and  Stimuplex  A® (B.  Braun,  Melsungen,  Germany;
2 G,  50  mm)  was  used  as  a  block  needle.  After  administering
ocal anesthesia  at  the  marked  point  of  entry,  a  block  nee-
le was  used  to  search  for  movement  of  muscles  innervated
y the  nerves  of  the  brachial  plexus  Two  of  these  nerves
median, ulnar,  radial  or  .musculocutaneous  nerve)  were
ocalized and  an  equal  amount  of  local  anesthetic  (15  ml)
as administered  to  each  one.  Aspiration  test  was  repeated
nce in  every  5  ml  during  the  injections.  An  anesthesiologist
ho did  not  take  part  in  the  rest  of  the  study  prepared  the
ocal anesthetic  solutions  according  to  randomization  and
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nother  anesthesiologist  (CI)  who  was  unaware  of  the  syringe
ontent has  performed  all  the  block  procedures.  Group  B was
dministered 30  ml  0.5%  bupivacaine  and  Group  L  30  ml  0.5%
evobupivacaine. Five  minutes  after  the  end  of  injections,
he surgical  area  started  to  be  checked  with  the  pin-prick
est with  5  min  intervals.  Sensory  block  was  assesed  with
 point  scale  (0  =  No  sensory  loss,  1  =  Loss  of  sensation  to
in-prick, 2  =  Loss  of  sensation  to  touch)  and  motor  block
as evaluated  with  Modiﬁed  Bromage  Scale  (MBS;  0  =  Normal
uscle function,  1  =  Elbow  ﬂexion,  2  =  Wrist  ﬂexion,  3  =  Full
otor block)  and  recorded.
Motor  block  onset  time  was  taken  as  the  time  between
njection of  local  anesthetic  and  appearance  of  MBS  1,  while
ensory block  onset  time  was  taken  as  the  time  between
njection of  local  anesthetic  and  the  loss  of  pain  sensation
ith pin-prick  stimuli.  Surgery  was  allowed  when  ‘‘pin-
rick’’ was  positive  in  the  surgery  area.
Sensory  block  duration  was  deﬁned  as  the  duration
etween sensory  block  onset  and  ﬁrst  feeling  of  pain,  while
otor block  duration  was  the  time  between  motor  block
nset and  full  arm  mobility.  These  durations  were  deter-
ined based  on  patient  reports  at  postoperative  4th,  8th
nd 24th  hour.
SAP,  DAP,  MAP,  HR,  SpO2 of  patients  were  recorded  at
he beginning  of  surgery,  at  minutes  5,  10  and  15  of  block
dministration, and  thereafter  with  10  min  intervals.
In  case  of  pain  sensation  at  the  beginning  of  or  during  the
urgery, local  anesthetic  inﬁltration  (prilocaine,  5--10  ml  in
% concentration)  to  the  surgical  site  was  planned.  Admin-
stration 50  mcg  fentanyl  and/or  1  mg  midazolam  was  also
lanned in  cases  of  pain  or  stress  despite  local  inﬁltration.
he doses  would  be  recorded  if  administered.
All  patient  complaints  during  and  after  block,  all  block-
elated complications  and  side  effects  of  drugs  were
ecorded.
Postoperative pain  complaints  were  assessed  on  a
‘verbal rating  scale’’  (VRS)  (0:  no  pain,  1:  mild  pain,  2:
oderate pain,  3:  severe  pain  and  4:  unbearable  pain),  and
atient satisfaction  was  assessed  at  postoperative  hour  24
s ‘‘not  satisﬁed,  slightly  satisﬁed,  and  satisﬁed’’.  The  ﬁrst
nalgesic (diclofenac  iv)  dose  was  planned  in  case  of  VRS
2. When  patients  were  visited  in  the  clinic  at  hours  4--8
nd 24,  complaints  of  pain  and  total  amount  of  analgesics
aken were  recorded.
tatistical  analysis
s  a  result  of  the  power  analysis  we  performed,  it  was
ecided that  each  group  should  have  at  least  a minimum
f 26  cases  (80%  power  and  0.05%  ˛  error).  Considering  pos-
ible data  loss  due  to  technical  reasons,  both  groups  were
dmitted 30  patients.
Statistical  analyses  in  the  study  were  performed  by  using
he NCSS  2007  package.  Descriptive  statistical  methods  were
sed  as  well  as  repeated  analysis  of  variance  for  continuous
ata of  multiple  groups,  Newman  Keuls  multiple  comparison
est for  subgroup  comparisons,  independent  t  test  for  the
omparison of  paired  groups,  chi-square  test  for  the  com-
arison of  qualitative  data,  and  McNemar’s  test  for  the  time
nterval measurements  of  qualitative  data.  The  results  were
valuated  at  a  signiﬁcance  level  of  p  <  0.05.
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Table  1  Distribution  of  patients  with  respect  to  demographics  (mean  ±  SD).
Group  B  Group  L  t  p
Age  (years)  40.3  ±  14.88  38.2  ±  11.44  0.96  0.643
Body  weight  (kg)  73.8  ±  12.59  73.9  ±  13.81  −0.03  0.977
Height  (cm)  171.43  ±  8.34  173.1  ±  7.98  −0.79  0.432
Table  2  Distribution  of  patients  with  respect  to  gender  and  ASA  classiﬁcation.
Group  B  Group  L
Gender
Male  22  73.30%  22  73.30%  2:  0
Female 8  26.70%  8  26.70%  p  =  1
ASA
I 19  63.30%  22  73.30%
II  9  30.00%  8  26.70%  2:  2.27
III 2  6.70%  0.00%  p  =  0.32
Table  3  Comparison  of  groups  with  respect  to  peroperative  fentanyl  use,  VRS  at  postoperative  hour  24  and  satisfaction.
Group  B  Group  L
Perop.  fentanyl
No fentanyl  use 23  76.70% 22  73.30%
50 mcg 4  13.30% 3  4.00%  2:  2.18
>50  mcg  3  10.00%  5  16.70%  p  =  0.534
Postop.  VRS  (Hour  24)
No pain  5  16.70%  2  6.70%
Mild pain  20  66.70%  13  43.30%
Moderate  pain  3  10.00%  13  43.30%  2:  9.02
Severe  pain  2  6.70%  2  6.70%  p  =  0.029
Postop  satisfaction  (Hour  24)
Not  satisﬁed  3  10.00%  3  10.00%
Slightly  satisﬁed  --  0.00%  1  3.30%  2:  1.01
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Results
The  study  was  implemented  on  60  patients  and  no  data
loss occurred.  No  statistically  signiﬁcant  difference  existed
between the  demographic  data  and  ASA  distributions  of  the
patients (Tables  1 and  2).  HR,  SAP,  DAP,  MAP  and  SpO2 val-
ues were  similar  at  all  measurement  times  in  comparisons
within and  between  the  groups.
The  patients  in  Groups  B  and  L  had  similar  peropera-
tive opioid  use  and  postoperative  satisfaction  rate  (Table  3).
w
m
Table  4  Surgery,  motor  and  sensory  block  durations  (mean  hour  ±
Group  B  
Surgery  duration 1.48  ±  0.61
Motor  block  duration  14.55  ±  5.55  
Sensory  block  duration  14.25  ±  5.81  26  86.70%  p  =  0.601
ean  postoperative  VRS  scores  of  Group  L  patients  was
igher than  that  of  Group  B  patients  (p  <  0.05).  Thirteen
atients (43.3%)  in  Group  L  and  3  patients  (10%)  in  Group
 had  moderate  pain  (Table  3).
The  operation  duration,  motor  and  sensory  block  times
f patients  in  Group  B  and  Group  L  did  not  vary  signiﬁcantly.
he sensory  and  motor  block  onset  times  in  Group  B  patients
ere shorter  than  Group  L  (p  <  0.05)  (Table  4).
Motor block  scores  of  Group  B  and  Group  L  patients  at
inutes 1,  5,  10,  15,  20,  30,  45  and  60  were  not  statistically
 SD).
Group  L  t  p
1.52 ±  0.66 −0.20 0.84
13.8  ±  2.95  0.73  0.468
12.81  ±  3.32  1.12  0.268
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Table  5  Motor  and  sensory  block  onset  times  (mean  minute  ±  SD).
Group  B  Group  L  p
Motor  block  onset  time  5.07  ±  4.07  9.2  ±  7.9  0.0041
 25.66  ±  10.72  0.036
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Table  6  Distribution  of  mean  motor  block  score  by  time  in
groups  with  respect  to  MBS  and  patient  ratio.
Minute  Group  B  Group  L
1  0  0
5  1  (33.3%)* 1  (13.3%)
10 2  (26.7%)* 2  (16.7%)
15 3  (20.0%)* 3  (3.3%)
20 3  (36.7%)* 3  (10.0%)
30 3  (53.3%)  3  (40.0%)
45 3  (63.3%)  3  (46.7%)
wSensory  block  onset  time  19.64  ±  10.70
ifferent  at  shoulder  level.  The  rate  of  full  motor  block  (MBS
) at  minutes  1,  5  and  10  in  the  shoulder  region  of  Group  B
atients was  higher  than  that  in  Group  L  patients.  However,  a
tatistically meaningful  difference  was  not  found  in  the  com-
arison  of  all  time  intervals  including  these.  No  statistical
ifference was  observed  between  motor  block  distribution
f Group  B  and  L  patients  at  elbow  level  at  all  measurement
imes.
While partial  block  in  the  ﬁngers  was  seen  in  12  patients
n Group  L  (40%),  it  was  seen  in  7  patients  (23.3%)  in  Group
. The  difference  was  not  statistically  signiﬁcant  (Table  5).
Patient  assessment  according  to  MBS  showed  that  there
ere more  patients  in  Group  B  who  had  higher  block  quality
t minutes  5,  10,  15  and  20  than  in  Group  L  (Table  6).
No  statistical  difference  existed  between  the  sensory
lock assessment  of  Group  B  and  L  patients  at  minutes  1,  15,
0,  30,  45  and  60.  Sensory  block  ratio  in  Group  B  patients
as statistically  higher  than  those  in  Group  L at  minutes  5
nd 10  (p  <  0.05)  (Table  7).
Among  both  groups  of  patients,  the  distribution  of  surgery
reas was  similar  (Table  8).
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Table  7  Sensory  block  assessment  in  groups  with  respect  to  time
Sensory  Group  B  
Min.  1
None  30  100.00%  
Min. 5
None  26  86.70%  
Full  4  13.30%*
Min. 10
None  20  66.70%  
Full  10  33.30%*
Min. 15
None  16  53.30%  
Full  14  46.70%  
Min. 20
None  9  30.00%  
Full  21  70.00%  
Min. 30
None  3  10.00%  
Full  27  90.00%  
Min. 45
None  2  6.70%  
Full  28  93.30%  
Min. 60
None  1  3.30%  
Full  29  96.70%  
* p < 0.05.60 3  (66.7%)  3  (56.7%)
* p < 0.05.
Partial  block  occurred  in  4  patients  in  Group  B.  All  four
ere given  peroperative  50  mcg  fentanyl  due  to  pain.  Addi-
ional local  anesthetics  were  administered  to  one  patient
y the  surgery  team  due  to  mild  pain  at  the  beginning  of
urgery. General  anesthesia  was  initiated  in  three  patients
10%) due  to  blockage  failure.
.
Group  L
30  100.00%
30  100.00%  2:  4.28
0.00%  p  =  0.038
29  96.70%  2:  9.01
1  3.30%  p  =  0.003
21  70.00%  2:  1.76
9  30.00%  p  =  0.184
12  40.00%  2:  0.659
18  60.00%  p  =  0.417
6  20.00%  2:  1.17
24  80.00%  p  =  0.278
0  0.00%  2:  2.06
30  100.00%  p  =  0.15
0  0.00%  2:  1.01
30  100.00%  p  =  0.313
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Table  8  Distribution  of  surgical  areas  in  the  groups.
AREA  Group  B  Group  L
ARM  1  (3.3%) 2 (6.6%)
ELBOW 2  (6.6%)  1  (3.3%)
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gFOREARM 7  (23.3%)  7  (23.3%)
WRIST --  HAND  20  (66.8%)  20  (66.8%)
Eleven  patients  in  Group  L  experienced  partial  block.  As
there was  mild  pain  during  surgery  in  2  patients,  the  surgery
team administered  local  anesthesia.  Two  others  needed
50 mcg  peroperative  fentanyl  due  to  pain.  Six  patients  (20%)
required general  anesthesia.
Motor  and  sensory  block  recovery  times  of  patients  who
required general  anesthesia  were  also  recorded  at  the  end
of surgery.
In the  postoperative  stage,  16  patients  in  Group  B  and  17
in Group  L  were  administered  analgesic  drugs  due  to  VRS  >3.
Other  patients  did  not  need  postoperative  analgesic  drugs
within the  ﬁrst  24  h.  The  mean  time  before  the  need  for
ﬁrst postoperative  analgesia  was  16.61  ±  8.05  h  in  Group  B
and  14.37  ±  7.27  h  in  Group  L.  The  difference  was  not  sta-
tistically signiﬁcant.
Side  effects
Group  B  patients  experienced  signiﬁcantly  more  side  effects
than Group  L.  Four  patients  in  Group  B  (13.3%)  suffered  from
side effects,  while  none  in  Group  L  did.
Two  patients  in  Group  B  had  Horner’s  syndrome  and  the
other 2  had  prolonged  motor  blockage  (longer  than  24  h).
These side  effects  were  not  seen  in  any  of  the  patients
in Group  L.  Full  recovery  was  observed  at  8th  hr  visit  of
patients who  suffered  Horner’s  syndrome.
Discussion
An  advantage  of  supraclavicular  block  is  that  the  upper
extremity position  does  not  affect  application  negatively
during the  procedure.4,5 Even  though  blocks  with  ultrasound
are known  to  yield  more  successful  outcomes,  the  impor-
tance of  experience  is  also  mentioned  in  previous  studies.6,7
We  therefore  preferred  nerve  stimulator  (NS)  in  our  study  as
we had  more  experience  with  it.  Our  successful  block  rate
with NS  was  90%  in  Group  B  and  80%  in  Group  L.
Despite  the  high  doses  of  bupivacaine  and  levobupi-
vacaine used  in  peripheral  blocks,  serious  cardiovascular,
pulmonary or  neurological  complications  are  rare.8--13 Our
results are  also  similar.
Cox et  al.14 compared  bupivacaine  and  levobupivacaine
in brachial  plexus  block.  They  found  no  difference  between
the dose-dependent  effects  of  0.25%  and  0.5%  levobupi-
vacaine; however,  they  found  that  0.25%  levobupivacaine
had slower  onset,  shorter  maintenance  and  a  lower  overall
success rate  than  the  other  two  groups  (0.5%  levobupiva-
caine, 0.5%  bupivacaine).  They  reported  a  general  success
rate of  65--80%  in  relation  to  the  anesthesia  technique.  This
study found  levobupivacaine  to  be  appropriate  for  brachial
plexus block.  Its  lower  toxic  potential  than  bupivacaine  also
supports this,  and  levobupivacaine  is  expected  to  increase
the safety  margin  in  regional  anesthesia.  No  statistically
1
G
t
E181
eaningful  difference  was  found  between  the  sensory  and
otor block  onset  times  of  the  two  drugs.
In  our  study,  the  motor  and  sensory  block  onset  times
ere meaningfully  shorter  in  Group  B  than  Group  L
p <  0.05).  Mean  motor  block  onset  time  was  5 min  in  Group
 and  9  min  in  Group  L,  while  mean  sensory  block  onset  time
as 19  min  in  Group  B  and  25  min  in  Group  L.  Even  though
here is  a statistical  difference  between  the  two  drugs,  we
re of  the  opinion  that  a  6  min  difference  is  not  of  signiﬁ-
ance in  clinical  application.
Another noteworthy  ﬁnding  from  Cox  et  al.’s14 study
s that  0.5%  levobupivacaine  had  the  longest  effect
uration. They  found  that  sensory  block  duration  was
92 min  (approximately  14  h)  with  0.25%  levobupivacaine;
.039 min  (approximately  17  h)  with  0.5%  levobupivacaine;
nd 896  min  (approximately  15  h)  with  0.5%  bupivacaine.
s on  sensory  block,  0.5%  levobupivacaine  had  the  longest
ffect duration  on  motor  block  as  well  (approximately
7.5 h).  However,  the  difference  between  groups  regarding
ensory and  motor  block  maintenance  duration  and  block
evel was  not  statistically  meaningful.  Our  results  also  cor-
oborate these  ﬁndings.
Lisanantti  et  al.13 found  no  meaningful  difference  with
espect to  sensory  block  quality  between  (45  ml  and  0.5%
oncentration) ropivacaine,  levobupivacaine  and  bupiva-
aine at  minutes  5,  10  and  15.  There  was  a  higher  rate
f achieving  anesthesia  at  a  desired  level  at  min  45  with
opivacaine and  bupivacaine  than  in  comparison  with  lev-
bupivacaine. The  frequency  of  obtaining  sensory  and  motor
lock at  min  45  was  similar  across  all  3  groups.  Mean  total
ensory block  duration  was  17.1  ±  6.5  h  in  the  levobupi-
acaine group,  17.8  ±  7.2  h  in  the  bupivacaine  group  and
5.0 ±  5.4  h  in  the  ropivacaine  group.  The  difference  was  not
tatistically  signiﬁcant.  Mean  total  motor  block  durations
ere 19.5  ±  8.0  h with  levobupivacaine,  19.3  ±  7.7  h  with
upivacaine, and  17.3  ±  6.6  h  with  ropivacaine.  D’Ambrosio
t al.15 compared  0.5%  concentrations  of  ropivacaine,
upivacaine and  levobupivacaine  in  two  different  blocks
brachial and  femoral),  and  found  that  ropivacaine  provided
aster block  but  had  a shorter  analgesia  duration  than  the
ther two.  They  did  not  observe  a difference  between  lev-
bupivacaine and  bupivacaine.  No  drug  induced  side  effects
rose in  the  study  and,  considering  the  potential  cardiotoxic
nd neurotoxic  side  effects  of  bupivacaine,  the  authors  con-
luded that  ropivacaine  or  levobupivacaine  could  be  used
epending on  the  need  for  anesthetic.
In  our  study,  we  did  not  found  a  statistical  difference
etween the  total  motor  and  sensory  block  durations  of  the
wo groups.  Compared  to  similar  studies,  sensory  block  dura-
ion with  levobupivacaine  was  similar  while  that  of  motor
lock was  shorter.  This  difference  may  be  attributed  to  dif-
erences in  technique  and  methods.
Postoperative  VRS  values  in  the  study  by  D’Ambrosio
t al.15 were  higher  in  the  ropivacaine  group  than  the
ther two  (levobupivacaine  and  bupivacaine).  No  differ-
nce existed  between  the  levobupivacaine  and  bupivacaine
roups.
In our  study,  VRS  at  postoperative  hour  24  in  Group  B  was
 in  20  patients,  2  in  three  patients,  and  3  in  two  patients.  In
roup L,  it  was  1  in  13  patients,  2  in  13,  and  3  in  2.  This  shows
hat VRS  values  were  better  in  Group  B  than  in  Group  L.
ven though  postoperative  pain  levels  were  lower  in  Group
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182  
 patients  than  those  in  Group  L,  we  are  of  the  opinion  that
he difference  is  not  signiﬁcant  in  clinical  practice  since  the
cores are  below  3.
Regarding postoperative  analgesia,  Liisanantti  et  al.13
ound  that  ﬁrst  postoperative  analgesia  was  needed  at
7.8 ±  7.2  h  in  the  bupivacaine  group,  17.1  ±  6.5  h  in  the
evobupivacaine group,  and  15.0  ±  5.4  h  in  the  ropivacaine
roup. The  difference  was  not  statistically  meaningful.
’Ambrosio et  al.15 did  not  ﬁnd  any  difference  regard-
ng postoperative  analgesia  need  with  levobupivacaine
nd bupivacaine.  Our  results  corroborate  this  ﬁnding.Cox14
tates  that  a  sharp  decline  from  0.2%  to  0.01%  has  been
bserved in  the  last  30  years  in  incidences  of  systemic
oxicity with  local  anesthetics,  and  that  even  though  the
ncidence of  systemic  toxicity  is  highest  in  peripheral  nerve
locks with  7.5  in  10,000,  the  incidence  of  neural  damage
s lowest  at  1.9  in  10,000.  In  our  study,  Horner’s  syndrome
ccurred in  2  patients  and  prolonged  paresthesia  occurred
n another  2  in  Group  B.  No  complications  were  noted  in
roup L.  No  toxicity  ﬁndings  related  to  bupivacaine  or  lev-
bupivacaine was  present  in  either  group.  On  follow-up,  a
ermanent neurological  disorder  was  not  detected  in  any  of
he patients  who  developed  complications.
In  sum,  we  found  that  30  ml  0.5%  bupivacaine  and  lev-
bupivacaine was  enough  to  obtain  motor  and  sensory
upraclavicular block.  Considering  the  higher  side  effect
ate of  bupivacaine  and  its  potential  cardotoxic  side  effects,
e are  of  the  opinion  that  levobupivacaine  may  be  the
referred drug  for  brachial  plexus  blocks  with  the  supra-
lavicular approach.
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